Location: Home
  • search
  • go
  • Relate News
  • 10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
  • 10/13/2025Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...
  • 10/13/2025Walgreens Boots Alliance Fully Exits Nanjing Pharma
  • 10/13/2025Hope Medicine Reports Positive Global Phase 2 Results for HMI-115
  • 10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...
  • 10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
  • 10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
  • 10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...
  • 10/8/2025China Biopharma Financing Rebounds in September as IPO Pipeline Surges
  • 10/8/2025License-Out Deals in China Drop Sharply in September Amid Steady Deal ...
  • 10/8/2025Only Two Novel Drugs Win China Approval in September as Local Innovati...
  • 10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242
  • 10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E
  • 10/1/2025China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Oversight
  • 9/30/2025China's Biopharma Sector Sees Surge in IPO Activity on HKEX and SSE
  • 9/30/2025China Issues Detailed Rules on Pre-Approval Import of Overseas Drugs
  • 9/30/2025Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff ...
  • 9/29/2025Novatim Strikes Licensing Deal for Dual-Target CAR-T Therapy as China ...
  • 9/29/2025China Eliminates 30% Import Duty on Indian Drugs Amid Global Trade Shi...
  • 9/26/2025China's Innovative Drug Market Shows Diverging Trends Between Hospital...
  • 9/26/2025Recent Official and Executive Moves
  • 9/25/2025SystImmune to Unveil New Clinical Data on Two ADC Programs at ESMO 202...
  • 9/24/2025Hengrui's ADC SHR-A181 Lands $1.1B Licensing Deal with Glenmark
  • 9/24/2025NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric Cancer
  • 9/23/2025KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb CM336
  • 9/23/2025MicuRx Plans Private Placement to Raise Up to ¥1B
  • 9/23/2025Innovent's Weight-Loss Drug Challenges Western Giants in China's Obesi...
  • 9/23/2025China Unveils New Rules for 11th Round of National Centralized Drug VB...
  • 9/23/2025CMS and Generix Join Forces for Innovative Biologics
  • 9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)
  • Page:1/368 Total number of articles:11038: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group